Upgrade to SI Premium - Free Trial

Natera (NTRA)

220.11 +3.14 (1.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Natera board expands to 12 with appointment of Thomas Lynch June 16, 2026 4:11 PM - StreetInsider Form 8-K/A Natera, Inc. For: Jun 02 June 16, 2026 4:09 PM - SEC Filing Form 8-K Natera, Inc. For: Jun 11 June 16, 2026 4:08 PM - SEC Filing Form 144 Natera, Inc. Filed by: Chapman Rowan E June 16, 2026 4:03 PM - SEC Filing Form 144 Natera, Inc. Filed by: Rabinowitz Matthew June 12, 2026 4:42 PM - SEC Filing RBC Capital Starts Natera (NTRA) at Outperform June 11, 2026 4:06 PM - StreetInsider Form 4 Natera, Inc. For: Jun 05 Filed by: Marcus Gail Boxer June 9, 2026 9:05 PM - SEC Filing Form 3 Natera, Inc. For: Jun 02 Filed by: Lynch Thomas J. Jr. June 9, 2026 6:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 04 Filed by: Chapman Steven Leonard June 5, 2026 9:05 PM - SEC Filing Form 144 Natera, Inc. Filed by: Marcus Gail Boxer June 5, 2026 5:15 PM - SEC Filing Form 8-K Natera, Inc. For: Jun 02 June 5, 2026 4:08 PM - SEC Filing Goldman Sachs Starts Natera (NTRA) at Neutral June 5, 2026 2:33 AM - StreetInsider Form 144 Natera, Inc. Filed by: Chapman Steven Leonard June 4, 2026 5:04 PM - SEC Filing Natera partners with CytoDyn for colorectal cancer drug development June 4, 2026 8:01 AM - StreetInsider Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer June 4, 2026 8:00 AM - BizWire Form 4 Natera, Inc. For: Jun 01 Filed by: Moshkevich Solomon June 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: May 29 Filed by: Rubin Eric H June 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Jun 01 Filed by: BOTHA ROELOF June 3, 2026 4:40 PM - SEC Filing Natera adds oncology experts Lynch and Rubin to board of directors June 3, 2026 8:01 AM - StreetInsider Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors June 3, 2026 8:00 AM - BizWire Wolfe Research Assumes Natera (NTRA) at Outperform June 1, 2026 4:24 PM - StreetInsider Form 144 Natera, Inc. Filed by: BOTHA ROELOF June 1, 2026 4:13 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon June 1, 2026 4:07 PM - SEC Filing Natera (NTRA) Announces Collaboration with Diakonos Oncology for Signatera in Refractory Melanoma May 29, 2026 6:03 AM - StreetInsider Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma May 29, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: May 26 Filed by: Fesko John May 28, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: May 26 Filed by: Moshkevich Solomon May 28, 2026 9:05 PM - SEC Filing Natera Enrolls First Patients in SIGNAL-ER 101, a Prospective, Interventional Study Evaluating MRD-Guided Therapy in Breast Cancer May 28, 2026 6:00 AM - BizWire Natera enhances Panorama prenatal test with deep sequencing technology May 26, 2026 6:02 AM - StreetInsider Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology May 26, 2026 6:00 AM - BizWire Natera to present 35 studies at ASCO meeting on cancer diagnostics May 21, 2026 5:05 PM - StreetInsider Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology May 21, 2026 5:05 PM - BizWire Natera expands Austin operations, plans what it calls world's largest sequencing facility May 21, 2026 7:00 AM - StreetInsider Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World May 21, 2026 7:00 AM - BizWire Natera's fetal genetic testing trial enrolls over 2,000 patients May 20, 2026 7:02 AM - StreetInsider EXPAND Trial of Natera’s Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled May 20, 2026 7:00 AM - BizWire Form 4 Natera, Inc. For: May 08 Filed by: Sheena Jonathan May 15, 2026 9:05 PM - SEC Filing FDA approves Natera's Signatera CDx for bladder cancer treatment decisions May 15, 2026 12:55 PM - StreetInsider Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) May 15, 2026 12:45 PM - BizWire FDA approves Genentech's Tecentriq for bladder cancer treatment May 15, 2026 12:32 PM - StreetInsider Natera (NTRA) PT Lowered to $250 at BTIG May 11, 2026 8:44 AM - StreetInsider Natera (NTRA) PT Raised to $265 at Baird May 8, 2026 7:58 AM - StreetInsider Natera (NTRA) PT Raised to $220 at Wells Fargo May 8, 2026 6:56 AM - StreetInsider Form 10-Q Natera, Inc. For: Mar 31 May 8, 2026 6:06 AM - SEC Filing Natera (NTRA) Misses Q1 EPS by 6c; raises guidance May 7, 2026 4:42 PM - StreetInsider Form 8-K Natera, Inc. For: May 07 May 7, 2026 4:13 PM - SEC Filing Natera Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - BizWire Form 4 Natera, Inc. For: May 04 Filed by: Rabinowitz Matthew May 6, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Brophy Michael Burkes May 5, 2026 9:45 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Moshkevich Solomon May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Chapman Steven Leonard May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Fesko John May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: Sheena Jonathan May 5, 2026 9:36 PM - SEC Filing Form 4 Natera, Inc. For: May 01 Filed by: RABINOWITZ DANIEL May 5, 2026 9:35 PM - SEC Filing Form 144 Natera, Inc. Filed by: Brophy Michael Burkes May 4, 2026 4:53 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon May 1, 2026 4:09 PM - SEC Filing Form SCHEDULE 13G Natera, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 11:29 AM - SEC Filing Natera to Report its First Quarter Results on May 7, 2026 April 30, 2026 8:00 AM - BizWire Form 4 Natera, Inc. For: Apr 27 Filed by: Brophy Michael Burkes April 29, 2026 9:45 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Chapman Steven Leonard April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: RABINOWITZ DANIEL April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Sheena Jonathan April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Moshkevich Solomon April 29, 2026 9:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 27 Filed by: Fesko John April 29, 2026 9:35 PM - SEC Filing Form 144 Natera, Inc. Filed by: Brophy Michael Burkes April 29, 2026 4:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Chapman Rowan E April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Marcus Gail Boxer April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Bertagnolli Monica April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Williams Brinkley Ruth April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: BOTHA ROELOF April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Baynes Roy D. April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: Rubin Eric H April 28, 2026 8:35 PM - SEC Filing Form 4 Natera, Inc. For: Apr 24 Filed by: ROSENMAN HERM April 28, 2026 8:35 PM - SEC Filing Barclays: Life science insiders sold $187M in stock during first quarter April 28, 2026 9:18 AM - StreetInsider Form DEFA14A Natera, Inc. April 23, 2026 7:03 PM - SEC Filing Form ARS Natera, Inc. For: Dec 31 April 23, 2026 7:03 PM - SEC Filing Form DEF 14A Natera, Inc. For: Jun 11 April 23, 2026 7:03 PM - SEC Filing Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT April 22, 2026 9:00 AM - BizWire Form 4 Natera, Inc. For: Apr 17 Filed by: Sheena Jonathan April 21, 2026 9:05 PM - SEC Filing William Blair Starts Natera (NTRA) at Outperform April 13, 2026 4:02 PM - StreetInsider Natera (NTRA) PT Lowered to $268 at TD Cowen April 13, 2026 8:51 AM - StreetInsider Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma April 13, 2026 8:00 AM - BizWire Form 3 Natera, Inc. For: Mar 26 Filed by: Rubin Eric H April 9, 2026 8:25 PM - SEC Filing Court awards Natera 30% ongoing royalty in patent dispute April 9, 2026 6:00 AM - StreetInsider Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents April 9, 2026 6:00 AM - BizWire Form 4 Natera, Inc. For: Apr 06 Filed by: Rabinowitz Matthew April 8, 2026 9:05 PM - SEC Filing 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform April 7, 2026 6:13 AM - BizWire Citi Adjusts Catalyst Watch List April 7, 2026 5:21 AM - StreetInsider Natera (NTRA) PT Lowered to $250 at Evercore ISI April 6, 2026 8:28 AM - StreetInsider Form 4 Natera, Inc. For: Apr 01 Filed by: Moshkevich Solomon April 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Apr 01 Filed by: RABINOWITZ DANIEL April 3, 2026 9:05 PM - SEC Filing Form 4 Natera, Inc. For: Mar 31 Filed by: Rabinowitz Matthew April 1, 2026 9:05 PM - SEC Filing Form 8-K Natera, Inc. For: Mar 26 April 1, 2026 4:16 PM - SEC Filing Form 144 Natera, Inc. Filed by: Moshkevich Solomon April 1, 2026 4:06 PM - SEC Filing SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery March 31, 2026 6:00 AM - BizWire Form SCHEDULE 13G/A Natera, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 10:52 AM - SEC Filing Form 4 Natera, Inc. For: Mar 18 Filed by: Sheena Jonathan March 20, 2026 9:05 PM - SEC Filing Form 144 Natera, Inc. Filed by: Sheena Jonathan March 20, 2026 1:07 PM - SEC Filing Form 144 Natera, Inc. Filed by: Sheena Jonathan March 18, 2026 11:20 AM - SEC Filing Full Article List